Comparison of Tissue Retractors During Cesarean Delivery in Obese Women
| Status: | Completed |
|---|---|
| Conditions: | Obesity Weight Loss |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 15 - Any |
| Updated: | 4/2/2016 |
| Start Date: | July 2006 |
| End Date: | June 2014 |
| Contact: | Jason K Baxter, MD, MSCP |
| Email: | jason.baxter@jefferson.edu |
| Phone: | (215) 955-9238 |
Randomized Controlled Trial of the Efficacy of the Mobius ™ Retractor in Performing Cesarean Sections in Patients With BMI ≥35kg/m2
This is a randomized controlled trial comparing the use of the Mobius™ retractor to the use
of traditional metal retraction instruments in non-urgent cesarean deliveries of obese
women. The Mobius™ retractor was designed for abdominal surgery to improve visualization of
the surgical field through standard surgical incisions and is now a standard instrument used
for cesarean deliveries at Thomas Jefferson University Hospital. We hypothesize that the use
of the Mobius™ retractor during cesarean deliveries in obese women decreases operative time,
blood loss, number of transfusions, infectious morbidity, incision length, and intra- /
post-operative antiemetic and pain medication use, while increasing surgeon satisfaction.
of traditional metal retraction instruments in non-urgent cesarean deliveries of obese
women. The Mobius™ retractor was designed for abdominal surgery to improve visualization of
the surgical field through standard surgical incisions and is now a standard instrument used
for cesarean deliveries at Thomas Jefferson University Hospital. We hypothesize that the use
of the Mobius™ retractor during cesarean deliveries in obese women decreases operative time,
blood loss, number of transfusions, infectious morbidity, incision length, and intra- /
post-operative antiemetic and pain medication use, while increasing surgeon satisfaction.
The Mobius™ retractor has been used in many obese cesarean deliveries based on the theory
that it provides superior visualization. There have been no clinical trials to determine if
this "added" exposure offers any measurable significant benefits to justify the added cost.
This study will determine if the Mobius™ retractor does provide a measurable difference in
outcomes, compared to the traditional retraction instruments.
that it provides superior visualization. There have been no clinical trials to determine if
this "added" exposure offers any measurable significant benefits to justify the added cost.
This study will determine if the Mobius™ retractor does provide a measurable difference in
outcomes, compared to the traditional retraction instruments.
Inclusion Criteria:
- pregnant women undergoing non-urgent cesarean delivery
Exclusion Criteria:
- women undergoing urgent cesarean delivery
- BMI <35kg/m2
- women undergoing vaginal delivery
- positive urine drug screen or known history of methadone maintenance or substance
abuse
We found this trial at
1
site
Thomas Jefferson University We are dedicated to the health sciences and committed to educating professionals,...
Click here to add this to my saved trials
